Skip to main content
logo
Monte Rosa Therapeutics, Inc. (GLUE)
NASDAQ: GLUE · Real-Time Price · USD
15.76
+1.54 (10.83%)
At close: Nov 24, 2025, 4:00 PM EST
15.58
-0.18 (-1.14%)
Pre-market: Nov 25, 2025, 4:41 AM EST

Monte Rosa Therapeutics Revenue

Monte Rosa Therapeutics had revenue of $12.77M in the quarter ending September 30, 2025, with 38.54% growth. This brings the company's revenue in the last twelve months to $181.54M, up 1,112.27% year-over-year. In the year 2024, Monte Rosa Therapeutics had annual revenue of $75.62M.

Revenue (ttm)
$181.54M
Revenue Growth
+1,112.27%
P/S Ratio
7.14
Revenue / Employee
$1,354,761
Employees
134
Market Cap
1.03B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202475.62M--
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings

GLUE News

More News